首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1820627

全球過敏診斷與治療市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Allergy Diagnostics And Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年07月01日 | 出版商:

Value Market Research | 英文 134 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球過敏診斷和治療市場預計將經歷顯著擴張，預計 2025 年至 2033 年的年複合成長率(CAGR) 為 9.26%。根據市場分析，預計到 2033 年底市場規模將達到 923.7 億美元，高於 2024 年的 416.3 億美元。

全球過敏診斷和治療市場正穩步成長，這得益於過敏性疾病盛行率的上升和診斷技術的進步。多重免疫測定、分子過敏學和即時檢測的創新正在提高診斷的準確性和患者分層。未來的發展將專注於個人化免疫療法、生物製劑和用於過敏管理的數位健康平台。

此外，人們對過敏診斷和治療的認知不斷提高，監管也越來越重視，這也擴大了市場機會。兒童和成人過敏人群的成長推動了對綜合診斷方案和標靶治療的需求。人工智慧和巨量資料分析的整合正在改善臨床決策。隨著過敏護理的進步，診斷和治療市場將持續發展，提供精準、以患者為中心且有效的解決方案。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第9章：過敏診斷與治療公司的競爭格局

過敏診斷和治療市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Pfizer Inc.

公司概況
公司收入
產品
最新動態

AbbVie Inc.

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Siemens Healthineers

公司概況
公司收入
產品
最新動態

Danaher Corporation

公司概況
公司收入
產品
最新動態

Alcon

公司概況
公司收入
產品
最新動態

BioMeRieux

公司概況
公司收入
產品
最新動態

EUROIMMUN Medizinische Labordiagnostika AG

公司概況
公司收入
產品
最新動態

AESKU.GROUP GmbH

公司概況
公司收入
產品
最新動態

DASIT Group SPA

公司概況
公司收入
產品
最新動態

Stallergenes Greer

公司概況
公司收入
產品
最新動態

HYCOR Biomedical

公司概況
公司收入
產品
最新動態

Minaris Medical America Inc.

公司概況
公司收入
產品
最新動態

Allergy Therapeutics

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

簡介目錄圖表

Product Code: VMR112115141

Global Allergy Diagnostics And Treatment Market is anticipated to experience remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 9.26% from 2025 to 2033. According to the market analysis, the market size is forecasted to reach USD 92.37 Billion by the end of 2033, up from USD 41.63 Billion in 2024.

The global allergy diagnostics and treatment market is experiencing steady growth driven by increasing prevalence of allergic diseases and advancements in diagnostic technologies. Innovations in multiplex immunoassays, molecular allergology, and point-of-care testing are enhancing diagnostic accuracy and patient stratification. Future developments will focus on personalized immunotherapy, biologics, and digital health platforms for allergy management.

Moreover, rising awareness and regulatory emphasis on allergy diagnosis and treatment are expanding market opportunities. The growth of pediatric and adult allergy populations is driving demand for comprehensive diagnostic panels and targeted therapies. Integration of AI and big data analytics is improving clinical decision-making. As allergy care advances, the diagnostics and treatment market will continue to evolve, delivering precise, patient-centric, and effective solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Allergy Diagnostics And Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Diagnostics
Therapeutics

By Allergen Type

Food
Inhaled
Drug
Other Allergens

By Test Type

In vivo Test
In vitro Test
List of Companies Profiled in the report
Pfizer Inc., AbbVie Inc., Sanofi, Thermo Fisher Scientific Inc., Siemens Healthineers, Danaher Corporation, Alcon, bioMerieux, EUROIMMUN Medizinische Labordiagnostika AG, AESKU.GROUP GmbH, DASIT Group SPA, Stallergenes Greer, HYCOR Biomedical, Minaris Medical America Inc., Allergy Therapeutics.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ALLERGY DIAGNOSTICS AND TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Allergen Type
- 3.7.3 Market Attractiveness Analysis By Test Type
- 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Diagnostics Historic and Forecast Sales By Regions
5.4. Therapeutics Historic and Forecast Sales By Regions

6. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET ANALYSIS BY ALLERGEN TYPE

6.1. Overview By Allergen Type
6.2. Historical and Forecast Data Analysis By Allergen Type
6.3. Food Historic and Forecast Sales By Regions
6.4. Inhaled Historic and Forecast Sales By Regions
6.5. Drug Historic and Forecast Sales By Regions
6.6. Other Allergens Historic and Forecast Sales By Regions

7. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET ANALYSIS BY TEST TYPE

7.1. Overview By Test Type
7.2. Historical and Forecast Data Analysis By Test Type
7.3. In vivo Test Historic and Forecast Sales By Regions
7.4. In vitro Test Historic and Forecast Sales By Regions

8. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ALLERGY DIAGNOSTICS AND TREATMENT COMPANIES

9.1. Allergy Diagnostics And Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ALLERGY DIAGNOSTICS AND TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Pfizer Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. AbbVie Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Sanofi
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Thermo Fisher Scientific Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Siemens Healthineers
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Danaher Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Alcon
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. BioMeRieux
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. EUROIMMUN Medizinische Labordiagnostika AG
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. AESKU.GROUP GmbH
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. DASIT Group SPA
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Stallergenes Greer
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. HYCOR Biomedical
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. Minaris Medical America Inc.
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. Allergy Therapeutics
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments